Chih-Hung Chang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chih-Hung Chang has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Cheng-Tzu Wang
Department of Orthopedic, Far Eastern Memorial Hospital, New Taipei City 10617, Taiwan
2 shared publications - Jwo-Luen Pao
Department of Orthopedic Surgery, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan
2 shared publications - Shang-Ming Lin
Department of Materials and Textiles, Asia Eastern University of Science and Technology, No. 58, Sec. 2, Sihchuan Rd., New Taipei City 220, Taiwan
2 shared publications - Chi-Ying Frederick Huang
Institute of Biopharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 11211, Taiwan
1 shared publication Chun-Hung Chen
GTESTing Laboratory, Hsinchu, Taiwan
1 shared publication- Feipei Lai
Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, New Taipei City 10617, Taiwan
1 shared publication
Latest Publications
- Open Access
The Effects of Comorbidities on Outcomes After Total Hip Replacement
Background: The relationship between comorbidity burden, as measured by the American Society of Anesthesiologists (ASA) classification, and functional recovery after total hip replacement (THR) remains uncertain. This study aimed to clarify whether ASA grade independently predicts postoperative patient-reported outcomes. Methods: We conducted a retrospective analysis of 218 consecutive patients from a prospectively maintained institutional registry who underwent primary unilateral THR between March 2021 and March 2024 in a single center. Patients were stratified into ASA 1–2 and ASA 3 groups. The Oxford Hip Score (OHS, 0–48) was collected preoperatively and at 1 week, 3 months, and 6 months postoperatively. Between-group differences were assessed, and multivariable linear regression was used to identify predictors of 6-month OHS. Results: Compared with ASA 1–2 patients, ASA 3 patients had lower preoperative OHS and longer hospital stay, but both groups showed substantial improvement over time and achieved excellent mean OHS at 6 months. In the adjusted model, higher ASA grade remained an independent negative predictor of 6-month OHS, whereas higher preoperative OHS and BMI were positive predictors. Conclusions: Despite presenting with worse baseline function and requiring longer hospitalization, ASA 3 patients experienced clinically meaningful recovery and achieved favorable 6-month outcomes after THR. Higher ASA status should therefore inform perioperative optimization rather than preclude surgery.
Open AccessThe Effects of Comorbidities on Outcomes After Total Hip Replacement
Background: The relationship between comorbidity burden, as measured by the American Society of Anesthesiologists (ASA) classification, and functional recovery after total hip replacement (THR) remains uncertain. This study aimed to clarify whether ASA grade independently predicts postoperative patient-reported outcomes. Methods: We conducted a retrospective analysis of 218 consecutive patients from a prospectively maintained institutional registry who underwent primary unilateral THR between March 2021 and March 2024 in a single center. Patients were stratified into ASA 1–2 and ASA 3 groups. The Oxford Hip Score (OHS, 0–48) was collected preoperatively and at 1 week, 3 months, and 6 months postoperatively. Between-group differences were assessed, and multivariable linear regression was used to identify predictors of 6-month OHS. Results: Compared with ASA 1–2 patients, ASA 3 patients had lower preoperative OHS and longer hospital stay, but both groups showed substantial improvement over time and achieved excellent mean OHS at 6 months. In the adjusted model, higher ASA grade remained an independent negative predictor of 6-month OHS, whereas higher preoperative OHS and BMI were positive predictors. Conclusions: Despite presenting with worse baseline function and requiring longer hospitalization, ASA 3 patients experienced clinically meaningful recovery and achieved favorable 6-month outcomes after THR. Higher ASA status should therefore inform perioperative optimization rather than preclude surgery.
- Open Access
- 9 October 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (19) , 2543
Simplifying Knee OA Prognosis: A Deep Learning Approach Using Radiographs and Minimal Clinical Inputs
Objectives: To predict the progression of knee osteoarthritis (OA), a deep convolutional neural network model was developed and applied to basic images and clinical data. Design: A vision transformer-based model was trained using 5565 knee radiographs as baseline images from the osteoarthritis initiative (OAI), including 578 testing images. Each knee had a corresponding Kellgren and Lawrence (KL) stage after 48 months of follow-up. Another 274 cases from the Far Eastern Memorial Hospital were used for external validation. The data included a combination of single/pairing images and full/essential clinical factors. Area under the receiver operating characteristics (AUROC), accuracy, sensitivity, specificity, odds ratio, and ability to discriminate surgical candidates were applied to evaluate model performance. Results: In cases with OA progression, the AUROC for identifying surgical candidates was 0.844, 0.804, 0.766, and 0.718 in the combination of a single image with essential factors, single image with full factors, pairing images with essential factors, and pairing images with full factors, respectively. In OAI testing using the simplest input, AUROC of identifying OA progression was 0.808, with 74.1% accuracy, 91.8% sensitivity, and 71% specificity. In external validation, AUROC of identifying OA progression was 0.709, with 71.2% accuracy, 72.2% sensitivity, and 70.3% specificity. Positive model prediction had an odds ratio of 23.87 (CI: 11.24~50.67) in OAI and 5.92 (CI: 3.50~10.03) in external validation. Conclusions: Our model provides reliable prediction results for knee OA cases with the advantages of simplicity and flexibility. The model performance was excellent in progression cases, potentially making early intervention in OA patients more efficient.
- 9 October 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (19) , 2543
Open AccessSimplifying Knee OA Prognosis: A Deep Learning Approach Using Radiographs and Minimal Clinical Inputs
Objectives: To predict the progression of knee osteoarthritis (OA), a deep convolutional neural network model was developed and applied to basic images and clinical data. Design: A vision transformer-based model was trained using 5565 knee radiographs as baseline images from the osteoarthritis initiative (OAI), including 578 testing images. Each knee had a corresponding Kellgren and Lawrence (KL) stage after 48 months of follow-up. Another 274 cases from the Far Eastern Memorial Hospital were used for external validation. The data included a combination of single/pairing images and full/essential clinical factors. Area under the receiver operating characteristics (AUROC), accuracy, sensitivity, specificity, odds ratio, and ability to discriminate surgical candidates were applied to evaluate model performance. Results: In cases with OA progression, the AUROC for identifying surgical candidates was 0.844, 0.804, 0.766, and 0.718 in the combination of a single image with essential factors, single image with full factors, pairing images with essential factors, and pairing images with full factors, respectively. In OAI testing using the simplest input, AUROC of identifying OA progression was 0.808, with 74.1% accuracy, 91.8% sensitivity, and 71% specificity. In external validation, AUROC of identifying OA progression was 0.709, with 71.2% accuracy, 72.2% sensitivity, and 70.3% specificity. Positive model prediction had an odds ratio of 23.87 (CI: 11.24~50.67) in OAI and 5.92 (CI: 3.50~10.03) in external validation. Conclusions: Our model provides reliable prediction results for knee OA cases with the advantages of simplicity and flexibility. The model performance was excellent in progression cases, potentially making early intervention in OA patients more efficient.
- Open Access
- 8 November 2022
- Published by Springer Nature in Tissue Engineering and Regenerative Medicine
- Vol. 19 (6) , 1295-1310
Mesenchymal Stem Cell Secreted-Extracellular Vesicles are Involved in Chondrocyte Production and Reduce Adipogenesis during Stem Cell Differentiation
Background: Extracellular vesicles (EVs) are derived from internal cellular compartments, and have potential as a diagnostic and therapeutic tool in degenerative disease associated with aging. Mesenchymal stem cells (MSCs) have become a promising tool for functional EVs production. This study investigated the efficacy of EVs and its effect on differentiation capacity. Methods: The characteristics of MSCs were evaluated by flow cytometry and stem cell differentiation analysis, and a production mode of functional EVs was scaled from MSCs. The concentration and size of EVs were quantitated by Nanoparticle Tracking Analysis (NTA). Western blot analysis was used to assess the protein expression of exosome-specific markers. The effects of MSC-derived EVs were assessed by chondrogenic and adipogenic differentiation analyses and histological observation. Results: The range of the particle size of adipose-derived stem cells (ADSCs)- and Wharton’s jelly -MSCs-derived EVs were from 130 to 150 nm as measured by NTA, which showed positive expression of exosomal markers. The chondrogenic induction ability was weakened in the absence of EVs in vitro. Interestingly, after EV administration, type II collagen, a major component in the cartilage extracellular matrix, was upregulated compared to the EV-free condition. Moreover, EVs decreased the lipid accumulation rate during adipogenic induction. Conclusion: The results indicated that the production model could facilitate production of effective EVs and further demonstrated the role of MSC-derived EVs in cell differentiation. MSC-derived EVs could be successfully used in cell-free therapy to guide chondrogenic differentiation of ADSC for future clinical applications in cartilage regeneration.
- 8 November 2022
- Published by Springer Nature in Tissue Engineering and Regenerative Medicine
- Vol. 19 (6) , 1295-1310
Open AccessMesenchymal Stem Cell Secreted-Extracellular Vesicles are Involved in Chondrocyte Production and Reduce Adipogenesis during Stem Cell Differentiation
Background: Extracellular vesicles (EVs) are derived from internal cellular compartments, and have potential as a diagnostic and therapeutic tool in degenerative disease associated with aging. Mesenchymal stem cells (MSCs) have become a promising tool for functional EVs production. This study investigated the efficacy of EVs and its effect on differentiation capacity. Methods: The characteristics of MSCs were evaluated by flow cytometry and stem cell differentiation analysis, and a production mode of functional EVs was scaled from MSCs. The concentration and size of EVs were quantitated by Nanoparticle Tracking Analysis (NTA). Western blot analysis was used to assess the protein expression of exosome-specific markers. The effects of MSC-derived EVs were assessed by chondrogenic and adipogenic differentiation analyses and histological observation. Results: The range of the particle size of adipose-derived stem cells (ADSCs)- and Wharton’s jelly -MSCs-derived EVs were from 130 to 150 nm as measured by NTA, which showed positive expression of exosomal markers. The chondrogenic induction ability was weakened in the absence of EVs in vitro. Interestingly, after EV administration, type II collagen, a major component in the cartilage extracellular matrix, was upregulated compared to the EV-free condition. Moreover, EVs decreased the lipid accumulation rate during adipogenic induction. Conclusion: The results indicated that the production model could facilitate production of effective EVs and further demonstrated the role of MSC-derived EVs in cell differentiation. MSC-derived EVs could be successfully used in cell-free therapy to guide chondrogenic differentiation of ADSC for future clinical applications in cartilage regeneration.